Jianmin Group was established in 1637 with its initial name ‘Yekaitai’；
It came into the market in Shanghai Stock Exchange in 2004；
Holley Group became the relative shareholder of Jianmin Group in 2005。
Jianmin Group（SH 600976），which focus on the development of traditional Chinese medicine and pediatric drugs, has become one of the national key traditional Chinese medicine enterprises and pediatric drug production bases. It is a China time-honored enterprise and one of the top 100 in Chinese pharmaceutical industry, as it owns two modern brands ‘Jianmin’ and ‘Longmu’ and a time-honored brand ‘Yekaitai’。
In Holley’s ‘Big Health’ industrial development strategy, concentrating on Chinese herbal pieces, combining with famous-region drugs, TCM diagnosis and treatment services and C2M intelligent manufacturing, Jianmin Group will fully develop its existed and new business, integrate industrial resources, reconstruct traditional Chinese medicine ecology and finally achieve the vision ‘ returning the traditional Chinese medicine as a lifestyle’.